[Lecture Report] The Asian Population and Development Association (APDA) Seminar: Roles of Science and Policy in the Pandemic Society (APDA, November 5, House of Representatives International Conference Center)
date : 11/24/2020
On November 5, 2020, HGPI Chairman Dr. Kiyoshi Kurokawa gave a lecture on the relationship between science and policy at the Asian Population and Development Association (APDA) “Roles of Science and Policy in the Pandemic Society” seminar. HGPI CEO and Board Member Mr. Ryoji Noritake also participated in the seminar, where he served as facilitator for a panel discussion.
Other speakers at the seminar included Mr. Yasuo Fukuda (Chair, APDA; Former Prime Minister of Japan), Mr. Kouji Tsuruoka (Former Ambassador Extraordinary and Plenipotentiary Embassy of Japan in the United Kingdom), Mr. Keizo Takemi (Member, House of Councilors), Mr. Hitoshi Kikawada (Member, House of Representatives), Professor Mitsunobu Kano (Professor, Graduate School of Integrated Health Science, Okayama University), and Dr. Osamu Kusumoto (Executive Director and Secretary General, APDA).
At the discussion, it was pointed out that while scientific data is important, policymakers must make decisions that are based on scientific data when implementing policy. Participants also expressed their high expectations for interdisciplinary cooperation in the scientific community that will draw upon expertise in many fields such as sociology, philosophy, and economics in addition to public health and medicine. During the discussion, there was also a proposal on the need to allow independent organizations to be the ones to conduct verification procedures when COVID-19 countermeasures are verified in the future.
The Asian Population and Development Association (APDA) Website
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)